RVTY

#867
Revvity, Inc.
93.9125 USD
+2.12%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
93.6000
94.1500
1年のレンジ
83.4800
118.2600
1日の変化
+2.12%
月次変化
+8.61%
6か月変化
-1.00%
1年の変化
-1.00%
以前の終値
91.9600
始値
93.6000
Bid
Ask
安値
93.6000
High
94.1500
ボリューム
50
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 10.4994 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
46.91
売上高対価格比率
3.96
1株当たり配当金
0.28
配当利回り（％）
0.29

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

ニュース